Spontaneously Hypertensive Rats (SHR) Are Resistant to a Reserpine-Induced Progressive Model of Parkinson's Disease: Differences in Motor Behavior, Tyrosine Hydroxylase and alpha-Synuclein Expression
dc.citation.volume | 9 | |
dc.contributor.author | Leão, Anderson Henrique França Figueiredo [UNIFESP] | |
dc.contributor.author | Meurer, Ywlliane da Silva Rodrigues | |
dc.contributor.author | Silva, Anatildes Feitosa | |
dc.contributor.author | Medeiros, André de Macêdo [UNIFESP] | |
dc.contributor.author | Campelo, Clarissa Loureiro Chagas | |
dc.contributor.author | Abílio, Vanessa Costhek [UNIFESP] | |
dc.contributor.author | Engelberth, Rovena Clara Galvão Januário | |
dc.contributor.author | Cavalcante, Jeferson de Souza | |
dc.contributor.author | Izídio, Geison Souza | |
dc.contributor.author | Ribeiro, Alessandra Mussi [UNIFESP] | |
dc.contributor.author | Silva, Regina Helena [UNIFESP] | |
dc.contributor.institution | Universidade Federal de São Paulo (UNIFESP) | |
dc.coverage | Lausanne | |
dc.date.accessioned | 2020-07-17T14:02:37Z | |
dc.date.available | 2020-07-17T14:02:37Z | |
dc.date.issued | 2017 | |
dc.description.abstract | Reserpine is an irreversible inhibitor of vesicular monoamine transporter-2 (VMAT2) used to study Parkinson's disease (PD) and screening for antiparkinsonian treatments in rodents. Recently, the repeated treatment with a low-dose of reserpine was proposed as a progressive model of PD. Rats under this treatment show progressive catalepsy behavior, oral movements and spontaneous motor activity decrement. In parallel, compared to Wistar rats, spontaneously hypertensive rats (SHR) are resistant to acute reserpine-induced oral dyskinesia. We aimed to assess whether SHR would present differential susceptibility to repeated reserpine-induced deficits in the progressive model of PD. Male Wistar and SHR rats were administered 15 subcutaneously (s.c.) injections of reserpine (0.1 mgkg) or vehicle, every other day and motor activity was assessed by the catalepsy, oral movements and open field tests. Only reserpine-treated Wistar rats presented increased latency to step down in the catalepsy test and impaired spontaneous activity in the open field. On the other hand, there was an increase in oral movements in both reserpine-treated strains, although with reduced magnitude and latency to instauration in SHR. After a 15-day withdrawn period, both strains recovered from motor impairment, but SHR animals expressed reduced latencies to reach control levels. Finally, we performed immunohistochemistry for tyrosine hydroxylase (TH) and a-synuclein (alpha-syn) 48 h after the last injection or 15 days after withdrawn. Reserpinetreated animals presented a reduction in TH and an increase in alpha-syn immunoreactivity in the substantia nigra and dorsal striatum (dSTR), which were both recovered after 15 days of withdraw. Furthermore, SHR rats were resistant to reserpine-induced TH decrement in the substantia nigra, and presented reduced immunoreactivity to a-syn inthe dSTR relative to Wistar rats, irrespective of treatment. This effect was accompanied by increase of malondaldhyde (MDA) in the striatum of reserpine-treated Wistar rats, while SHR presented reduced MDA in both control and reserpine conditions relative to Wistar strain. In conclusion, the current results show that SHR are resilient to motor and neurochemical impairments induced by the repeated low-dose reserpine protocol. These findings indicate that the neurochemical, molecular and genetic differences in the SHR strain are potential relevant targets to the study of susceptibility to PD. | en |
dc.description.affiliation | Univ Fed Rio Grande do Norte, Dept Physiol, Memory Studies Lab, Natal, RN, Brazil | |
dc.description.affiliation | Univ Fed Rio Grande do Norte, Brain Inst, Natal, RN, Brazil | |
dc.description.affiliation | Univ Fed Sao Paulo, Dept Pharmacol, Behav Neurosci Lab, Sao Paulo, Brazil | |
dc.description.affiliation | Univ Fed Sao Paulo, Dept Pharmacol, Sao Paulo, Brazil | |
dc.description.affiliation | Univ Fed Rio Grande do Norte, Dept Physiol, Neurochem Studies Lab, Natal, RN, Brazil | |
dc.description.affiliation | Univ Santa Catarina, Dept Cellular Biol Embryol & Genet, Lab Behav Genet, Florianopolis, SC, Brazil | |
dc.description.affiliation | Univ Fed Sao Paulo, Dept Biosci, Santos, Brazil | |
dc.description.affiliationUnifesp | Univ Fed Sao Paulo, Dept Pharmacol, Behav Neurosci Lab, Sao Paulo, Brazil | |
dc.description.affiliationUnifesp | Univ Fed Sao Paulo, Dept Pharmacol, Sao Paulo, Brazil | |
dc.description.affiliationUnifesp | Univ Fed Sao Paulo, Dept Biosci, Santos, Brazil | |
dc.description.source | Web of Science | |
dc.description.sponsorship | Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) | pt |
dc.description.sponsorship | Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) | pt |
dc.description.sponsorship | Fundação de Apoio à Pesquisa do Estado do Rio Grande do Norte (FAPERN) | pt |
dc.description.sponsorship | Pró-reitoria de Pesquisa da Universidade Federal do Rio Grande do Norte (PROPESQ/UFRN) | pt |
dc.description.sponsorship | Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) | pt |
dc.description.sponsorshipID | FAPESP: 2015/12308-5 | pt |
dc.description.sponsorshipID | FAPESP: 2015/03354-3 | pt |
dc.identifier | https://dx.doi.org/10.3389/fnagi.2017.00078 | |
dc.identifier.citation | Frontiers In Aging Neuroscience. Lausanne, v. 9, p. -, 2017. | |
dc.identifier.doi | 10.3389/fnagi.2017.00078 | |
dc.identifier.file | WOS000397394200001.pdf | |
dc.identifier.issn | 1663-4365 | |
dc.identifier.uri | https://repositorio.unifesp.br/handle/11600/54908 | |
dc.identifier.wos | WOS:000397394200001 | |
dc.language.iso | eng | |
dc.publisher | Frontiers Media Sa | |
dc.relation.ispartof | Frontiers In Aging Neuroscience | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | Reserpine | en |
dc.subject | Parkinson's disease | en |
dc.subject | SHR | en |
dc.subject | Alpha-synuclein | en |
dc.subject | Tyrosine hydroxylase | en |
dc.title | Spontaneously Hypertensive Rats (SHR) Are Resistant to a Reserpine-Induced Progressive Model of Parkinson's Disease: Differences in Motor Behavior, Tyrosine Hydroxylase and alpha-Synuclein Expression | en |
dc.type | info:eu-repo/semantics/article |
Arquivos
Pacote Original
1 - 1 de 1
Carregando...
- Nome:
- WOS000397394200001.pdf
- Tamanho:
- 3.79 MB
- Formato:
- Adobe Portable Document Format
- Descrição: